Année 2021

Inactivating PTH/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients.
Pereda A, Elli FM, Thiele S, de Sanctis L, Rothenbuhler A, Hanna P, Francou B, Ertl DA, Perez de Nanclares G, Linglart A, Mantovani G.
Eur J Endocrinol. 2021 Feb;184(2):311-320.

Antagonistic effects of finerenone and spironolactone on the aldosterone-regulated transcriptome of human kidney cells.
Le Billan F, Perrot J, Carceller E, Travers S, Viengchareun S, Kolkhof P, Lombès M, Fagart J.

FASEB J. 2021 Feb;35(2):e21314.

Clinical aspects of multiple endocrine neoplasia type 1.
Al-Salameh A, Cadiot G, Calender A, Goudet P, Chanson P.

Nat Rev Endocrinol. 2021 Feb 9.